Complement in pemphigus vulgaris and other bullous dermatoses.
The behavior of the complement  and of its components C4 and C3 has been studied in serum and in blister fluid both in patients with pemphigus vulgaris and other bullous dermatoses and in healthy subjects with experimentally induced blisters. The results are suggestive of local activation of the complement, in the blister fluid of patients with pemphigus vulgaris, pemphigus erythematosus and bullous pemphigoid according to the classical enzymatic sequence.
D001609:Beta-Globulins / Q000032:analysis; D001768:Blister / Q000276:immunology; D002056:Burns / Q000276:immunology; D002057:Burns, Chemical / Q000276:immunology; D003176:Complement C3 / Q000032:analysis; D003181:Complement C4 / Q000032:analysis; D003165:Complement System Proteins / Q000032:analysis*; D005122:Exudates and Transudates / Q000276:immunology; D005627:Frostbite / Q000276:immunology; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D010392:Pemphigus / Q000276:immunology*; D012872:Skin Diseases, Vesiculobullous / Q000276:immunology*
D001609:Beta-Globulins; D003176:Complement C3; D003181:Complement C4; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D003165:Complement System Proteins